Paying users zone. Data is covered by 
.
Get 1-month access to Regeneron Pharmaceuticals Inc. for $13.99, or
get full access to entire website for at least 3 months from $49.99.
We accept:
This is a one-time payment. There is no automatic renewal.
Regeneron Pharmaceuticals Inc. (REGN)
Adjustments to Financial Statements
Difficulty: Advanced
Adjustments to Current Assets
Regeneron Pharmaceuticals Inc., adjusted current assets
US$ in thousands
| Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | ||
|---|---|---|---|---|---|---|
| As Reported | ||||||
| Current assets | |
|
|
|
|
|
| Adjustments | ||||||
| Less: Current deferred tax assets1 | |
|
|
|
|
|
| After Adjustment | ||||||
| Adjusted current assets | |
|
|
|
|
|
Based on: 10-K (filing date: 2019-02-07), 10-K (filing date: 2018-02-08), 10-K (filing date: 2017-02-09), 10-K (filing date: 2016-02-11), 10-K (filing date: 2015-02-12).
1 Current deferred tax assets. See Details »
Adjustments to Total Assets
Regeneron Pharmaceuticals Inc., adjusted total assets
US$ in thousands
Based on: 10-K (filing date: 2019-02-07), 10-K (filing date: 2018-02-08), 10-K (filing date: 2017-02-09), 10-K (filing date: 2016-02-11), 10-K (filing date: 2015-02-12).
1 Operating lease right-of-use asset (before adoption of FASB Topic 842). See Details »
2 Current deferred tax assets. See Details »
3 Noncurrent deferred tax assets. See Details »
Adjustments to Current Liabilities
Regeneron Pharmaceuticals Inc., adjusted current liabilities
US$ in thousands
| Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | ||
|---|---|---|---|---|---|---|
| As Reported | ||||||
| Current liabilities | |
|
|
|
|
|
| Adjustments | ||||||
| Less: Deferred revenue, current portion | |
|
|
|
|
|
| After Adjustment | ||||||
| Adjusted current liabilities | |
|
|
|
|
|
Based on: 10-K (filing date: 2019-02-07), 10-K (filing date: 2018-02-08), 10-K (filing date: 2017-02-09), 10-K (filing date: 2016-02-11), 10-K (filing date: 2015-02-12).
Adjustments to Total Liabilities
Regeneron Pharmaceuticals Inc., adjusted total liabilities
US$ in thousands
Based on: 10-K (filing date: 2019-02-07), 10-K (filing date: 2018-02-08), 10-K (filing date: 2017-02-09), 10-K (filing date: 2016-02-11), 10-K (filing date: 2015-02-12).
1 Operating lease liability (before adoption of FASB Topic 842). See Details »
2 Noncurrent deferred tax liabilities. See Details »
Adjustments to Stockholders’ Equity
Regeneron Pharmaceuticals Inc., adjusted stockholders’ equity
US$ in thousands
Based on: 10-K (filing date: 2019-02-07), 10-K (filing date: 2018-02-08), 10-K (filing date: 2017-02-09), 10-K (filing date: 2016-02-11), 10-K (filing date: 2015-02-12).
1 Net deferred tax assets (liabilities). See Details »
Adjustments to Capitalization Table
Regeneron Pharmaceuticals Inc., adjusted capitalization table
US$ in thousands
Based on: 10-K (filing date: 2019-02-07), 10-K (filing date: 2018-02-08), 10-K (filing date: 2017-02-09), 10-K (filing date: 2016-02-11), 10-K (filing date: 2015-02-12).
1 Operating lease liability (before adoption of FASB Topic 842). See Details »
2 Net deferred tax assets (liabilities). See Details »
Adjustments to Revenues
Regeneron Pharmaceuticals Inc., adjusted revenues
US$ in thousands
| 12 months ended | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | |
|---|---|---|---|---|---|---|
| As Reported | ||||||
| Revenues | |
|
|
|
|
|
| Adjustments | ||||||
| Add: Increase (decrease) in deferred revenue | |
|
|
|
|
|
| After Adjustment | ||||||
| Adjusted revenues | |
|
|
|
|
|
Based on: 10-K (filing date: 2019-02-07), 10-K (filing date: 2018-02-08), 10-K (filing date: 2017-02-09), 10-K (filing date: 2016-02-11), 10-K (filing date: 2015-02-12).
Adjustments to Reported Income
Regeneron Pharmaceuticals Inc., adjusted net income
US$ in thousands
Based on: 10-K (filing date: 2019-02-07), 10-K (filing date: 2018-02-08), 10-K (filing date: 2017-02-09), 10-K (filing date: 2016-02-11), 10-K (filing date: 2015-02-12).
1 Deferred income tax expense (benefit). See Details »